arrow
J

Jaishri O. Blakeley

universite paris-est-creteil-val-de-marne (upec)
H指数:57
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D

神经纤维瘤病1型中与皮肤神经纤维瘤相关的污名化:cNF-PUSH-D的发展、验证及严重程度分层

2026-02-011
PRE
WINDOW OF OPPORTUNITY STUDY OF NIVOLUMAB AND IPILIMUMAB IN PEOPLE WITH NEUROFIBROMATOSIS TYPE 1 AND NEWLY DIAGNOSED MALIGNANT AND PRE-MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

神经纤维瘤病1型患者中新诊断的恶性及癌前周围神经鞘瘤的纳武利尤单抗和伊匹木单抗机会窗口研究

2025-11-010
OAAI
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: development and validation of the Nef-ASI.

神经纤维瘤病1型相关皮肤神经纤维瘤严重程度的测量:Nef-ASI的开发与验证。

2025-10-060
PRE
Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository dataset

NF1相关周围神经鞘瘤的整合基因组分析:一个更新的生物样本库数据集

2025-07-150
OAAI
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative

基于WHO ICF框架建立神经肿瘤学中使用的患者报告结局指标的内容效度:RANO-PRO计划的一部分

2025-06-010
PRE
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104

贝伐单抗对NF2相关性神经鞘瘤病中非靶点颅内脑膜瘤和非前庭神经鞘瘤的影响:NF104

2025-05-280
PRE